Palomar Medical LuxV
This article was originally published in The Gray Sheet
Executive SummaryAcne market entry is signaled by expanded 510(k) indication April 2 for use of the pulsed light system handpiece to treat mild to moderate forms of the skin condition. The device, which targets the sebaceous glands, previously was cleared to treat pigmented lesions...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.